bendamustine hydrochloride has been researched along with Polyneuropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, L; Bergamaschi, M; Briani, C; Demichelis, C; Ferrari, S; Garnero, M; Massa, F; Pesce, G; Schenone, A; Zuppa, A | 1 |
1 other study(ies) available for bendamustine hydrochloride and Polyneuropathies
| Article | Year |
|---|---|
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy.
Topics: Bendamustine Hydrochloride; Hematologic Neoplasms; Humans; Myelin-Associated Glycoprotein; Neoplasm Recurrence, Local; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Rituximab | 2020 |